Treatment with abacavir (Ziagen) does not have a significant effect on biomarkers that can indicate an increased risk of heart attack, Australian researchers report in a small study published in the November 30th edition... more>

Two cases of liver toxicity caused by the anti-HIV drug abacavir (Ziagen, also in the combination pill Kivexa) have been reported in the November 30th edition of AIDS. Both cases involved young women who... more>

Access to HIV testing and antiretrovirals for prevention of mother to child HIV transmission has grown substantially over the past four years in the countries most severely affected by HIV, UN agencies reported today – but around 40% of women... more>

today's news

• Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
• Rare abacavir liver side-effects reported